Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Director/PDMR Shareholding

28 Nov 2017 14:56

RNS Number : 7591X
Scapa Group PLC
28 November 2017
 

28 November 2017

SCAPA GROUP PLCDirector/PDMR Shareholding

 

Notification and public disclosure of transactions by persons discharging

managerial responsibilities ('PDMR')

 

Scapa Group plc (AIM: SCPA) (the "Company"), a global supplier of bonding solutions and manufacturer of adhesive-based products for the Healthcare and Industrial markets, announces that it was notified on 27 November 2017 that Graham Hardcastle, Group Finance Director of the Company, purchased 15,000 shares in the Company at a price of 481.6359 pence per share.

 

Following the purchase, Mr Hardcastle's holding is as follows:-

 

Director

No. of Ordinary Shares held prior to Purchase

No. of Ordinary Shares Purchased

No. of Ordinary Shares held following Purchase

Percentage of Issued Share Capital following Purchase

Graham Hardcastle

20,000

15,000

35,000

0.023%

 

In addition, the Company was notified on 28 November 2017 that Wendy Baker, Group General Counsel and Company Secretary, purchased 4,187 shares in the Company at a price of 476 pence per share.

The notifications set out in the Annex below, which were made in accordance with the requirements of Article 19 of the Market Abuse Regulation, provide further details of such purchases.

ANNEX

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Graham Hardcastle

 

2

Reason for the notification

 

a)

Position / status

Director

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transactions

Purchase of shares

 

c)

Price(s) and volume(s)

 

15,000 shares at 481.6359 pence per share

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transactions

 

27 November 2017

f)

Place of the transactions

 

London

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Wendy Baker

 

2

Reason for the notification

 

a)

Position / status

PDMR

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transactions

Purchase of shares

 

c)

Price(s) and volume(s)

 

4,187 shares at 476 pence per share

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transactions

 

28 November 2017

f)

Place of the transactions

 

London

 

For further information:

 

Scapa Group plc:

Wendy Baker +44 (0) 161 301 7400

Company Secretary

 

Numis Securities Limited: +44 (0) 20 7260 1000

Mark Lander/ Richard Thomas

(Joint Broker/Nominated Adviser)

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUWVSRBOAAUAA
Date   Source Headline
1st Mar 201710:22 amRNSAdditional Listing
23rd Feb 201711:03 amRNSHolding(s) in Company
16th Feb 20179:21 amRNSHolding(s) in Company
7th Feb 20174:16 pmRNSBlock listing Interim Review
3rd Feb 20173:53 pmRNSHolding(s) in Company
26th Jan 201710:10 amRNSDirector/PDMR Shareholding
25th Jan 20174:33 pmRNSBlock listing Interim Review
25th Jan 201711:49 amRNSHolding(s) in Company
23rd Jan 20179:18 amRNSDirector/PDMR Shareholding
9th Jan 20179:41 amRNSAdditional Listing
22nd Dec 20162:15 pmRNSAdditional Listing
15th Dec 20167:00 amRNSDirectorate Change
13th Dec 20161:29 pmRNSAdditional Listing
24th Nov 20164:30 pmRNSDirector/PDMR Shareholding
24th Nov 20164:20 pmRNSDirector/PDMR Shareholding
22nd Nov 20164:20 pmRNSAdditional Listing
22nd Nov 20167:00 amRNSHalf-year Report
12th Oct 20167:00 amRNSTrading Statement
27th Sep 20162:53 pmRNSDirector/PDMR Shareholding
21st Sep 20161:51 pmRNSAdditional Listing
6th Sep 201610:24 amRNSAdditional Listing
2nd Sep 201611:20 amRNSBlock listing Interim Review
31st Aug 20169:14 amRNSTotal Voting Rights
26th Aug 20167:00 amRNSDirector/PDMR Shareholding
12th Aug 201611:24 amRNSBlock listing Interim Review
11th Aug 20161:30 pmRNSDirector/PDMR Shareholding
10th Aug 201610:08 amRNSDirector/PDMR Shareholding
19th Jul 20164:58 pmRNSAdditional Listing
19th Jul 20167:00 amRNSAGM Statement
11th Jul 20163:48 pmRNSDirector/PDMR Shareholding
5th Jul 20162:25 pmRNSHolding(s) in Company
1st Jul 20162:58 pmRNSDirector/PDMR Shareholding
1st Jun 20163:49 pmRNSAdditional Listing
1st Jun 20167:00 amRNSAppointment of Joint Broker
24th May 20167:00 amRNSAcquisition
24th May 20167:00 amRNSFinal Results
18th May 201610:01 amRNSAdditional Listing
11th May 201610:45 amRNSHolding(s) in Company
18th Apr 20167:00 amRNSDirectorate Change
14th Apr 20167:00 amRNSTrading Statement
2nd Mar 20169:06 amRNSBlocklisting Interim Review
8th Feb 20169:49 amRNSBlocklisting Interim Review
28th Jan 20167:00 amRNSDirectorate Change
31st Dec 20157:00 amRNSTotal Voting Rights
15th Dec 20159:57 amRNSHolding(s) in Company
14th Dec 20158:26 amRNSHolding(s) in Company
14th Dec 20158:21 amRNSDirector/PDMR Shareholding
8th Dec 201511:46 amRNSHolding(s) in Company
8th Dec 201511:42 amRNSHolding(s) in Company
1st Dec 201510:52 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.